Safety and tolerability of single and multiple-ascending doses of the study drug ACP-014 in Healthy volunteers.
Phase 1
Completed
- Conditions
- Hypoparathyroidism
- Registration Number
- ACTRN12617001375347
- Lead Sponsor
- Ascendis Pharma Bone Diseases A/S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 186
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method